ATE400257T1 - Stabile pharmazeutische zusammensetzung mit linezolid form iv - Google Patents

Stabile pharmazeutische zusammensetzung mit linezolid form iv

Info

Publication number
ATE400257T1
ATE400257T1 AT06250227T AT06250227T ATE400257T1 AT E400257 T1 ATE400257 T1 AT E400257T1 AT 06250227 T AT06250227 T AT 06250227T AT 06250227 T AT06250227 T AT 06250227T AT E400257 T1 ATE400257 T1 AT E400257T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
linezolid form
composition containing
stable pharmaceutical
linezolid
Prior art date
Application number
AT06250227T
Other languages
English (en)
Inventor
Ruth Tenengauzer
Minutza Leibovici
Ben-Zion Solomon
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36129715&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE400257(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of ATE400257T1 publication Critical patent/ATE400257T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT06250227T 2005-07-20 2006-01-17 Stabile pharmazeutische zusammensetzung mit linezolid form iv ATE400257T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70143805P 2005-07-20 2005-07-20

Publications (1)

Publication Number Publication Date
ATE400257T1 true ATE400257T1 (de) 2008-07-15

Family

ID=36129715

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06250227T ATE400257T1 (de) 2005-07-20 2006-01-17 Stabile pharmazeutische zusammensetzung mit linezolid form iv

Country Status (14)

Country Link
US (1) US20070020329A1 (de)
EP (1) EP1749517B8 (de)
JP (1) JP2009501794A (de)
CN (1) CN101262853A (de)
AT (1) ATE400257T1 (de)
AU (1) AU2006277017A1 (de)
CA (1) CA2612481A1 (de)
DE (1) DE602006001699D1 (de)
DK (1) DK1749517T3 (de)
ES (1) ES2309920T3 (de)
IL (1) IL188176A0 (de)
PL (1) PL1749517T3 (de)
PT (1) PT1749517E (de)
WO (1) WO2007018588A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007102082A1 (en) * 2006-03-09 2007-09-13 Glenmark Pharmaceuticals Limited High oxazolidinone content solid dosage forms
WO2011080570A2 (en) * 2009-12-29 2011-07-07 Micro Labs Limited Extended release pharmaceutical composition comprising linezolid and process for preparing the same
US9132132B2 (en) * 2010-09-02 2015-09-15 Hetero Research Foundation Pharmaceutical compositions of linezolid
CN102885788B (zh) * 2011-07-22 2016-06-29 重庆华邦制药有限公司 一种晶型稳定的利奈唑胺片及其制备方法
WO2013088389A1 (en) * 2011-12-14 2013-06-20 Alembic Pharmaceuticals Limited Linezolid premix
CN103099792B (zh) * 2012-12-10 2014-11-26 成都欣捷高新技术开发有限公司 一种高载药量、体外快速溶出的iv晶型利奈唑胺片的制备方法
CN103893138B (zh) * 2012-12-28 2017-09-29 成都国为生物医药有限公司 一种含有利奈唑胺晶型ⅲ的片剂
CN104370846B (zh) * 2013-08-15 2017-04-12 杭州华东医药集团新药研究院有限公司 制备利奈唑胺ⅳ晶型的方法
CN104622831B (zh) * 2013-11-06 2018-06-22 江苏豪森药业集团有限公司 一种口服片剂及其制备方法
CN104173303B (zh) * 2014-08-14 2017-01-11 杭州华东医药集团新药研究院有限公司 一种含有利奈唑胺的组合物及其制备方法
CN104586812A (zh) * 2014-12-25 2015-05-06 杭州华东医药集团新药研究院有限公司 一种含有利奈唑胺的组合物及其制备方法
ES2704727T3 (es) * 2015-11-17 2019-03-19 Borealis Ag Composición de TPO de flujo elevado con excelente balance de propiedades mecánicas para interiores de automóviles
CN111675669A (zh) * 2020-05-15 2020-09-18 扬子江药业集团北京海燕药业有限公司 一种利奈唑胺结晶形式及其制备方法和药物组合物
CN118059106B (zh) * 2024-04-17 2024-06-28 山东新时代药业有限公司 一种利奈唑胺抗菌制剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
US6444813B2 (en) 2000-02-02 2002-09-03 Pharmacia & Upjohn Company Linezolid-crystal form II
AR027261A1 (es) * 2000-02-02 2003-03-19 Upjohn Co Linezolid forma cristalina ii
EP1265608B1 (de) * 2000-03-22 2008-10-29 Pharmacia & Upjohn Company LLC Oxazolidin tablettenformulierung
US6514529B2 (en) * 2000-03-22 2003-02-04 Pharmacia & Upjohn Company Oxazolidinone tablet formulation
ES2803516T3 (es) * 2003-10-16 2021-01-27 Symed Labs Ltd Una forma cristalina de linezolid
EP1658275A1 (de) * 2004-06-29 2006-05-24 Teva Pharmaceutical Industries Ltd Kristalline form iv von linezolid

Also Published As

Publication number Publication date
US20070020329A1 (en) 2007-01-25
EP1749517A1 (de) 2007-02-07
JP2009501794A (ja) 2009-01-22
EP1749517B8 (de) 2008-10-22
DE602006001699D1 (de) 2008-08-21
ES2309920T3 (es) 2008-12-16
PL1749517T3 (pl) 2008-12-31
HK1097774A1 (en) 2007-07-06
WO2007018588A8 (en) 2008-05-08
PT1749517E (pt) 2008-09-29
EP1749517B1 (de) 2008-07-09
WO2007018588A1 (en) 2007-02-15
AU2006277017A1 (en) 2007-02-15
CN101262853A (zh) 2008-09-10
IL188176A0 (en) 2008-03-20
CA2612481A1 (en) 2007-02-15
DK1749517T3 (da) 2008-11-03

Similar Documents

Publication Publication Date Title
IL188176A0 (en) Stable pharmaceutical composition comprising linezolid form iv
NO20075111L (no) Farmasoytisk sammensetning
EA201290833A1 (ru) Применение амисульприда в качестве противорвотного средства
ATE499090T1 (de) Pharmazeutische zusammensetzung mit hydrochlorothiazid und telmisartan
MY145590A (en) Phenylacetamides and their use as glucokinase modulators
IL196425A (en) Oral unit dose form containing ibuprofen and famotidine
GB0420888D0 (en) Compounds and uses
HRP20060147B1 (hr) Terapijski sustav s kontroliranim otpuštanjem za nazalnu primjenu
EA201070544A1 (ru) Новый класс терапевтических веществ, усиливающих диффузию низкомолекулярных соединений
WO2007062078A3 (en) Thrombopoietin activity modulating compounds and methods
CY1106430T1 (el) Φαρμακα για εισπνοη που πepιλαμβανουν βηταμιμητικα και αντιχολινepγικο
TW200716628A (en) Novel compounds
SE0401342D0 (sv) Therapeutic compounds
NO20044107L (no) Medikamenter inneholdende betamimetica og et nytt anticholinergisk legemiddel
ATE410424T1 (de) Spirocyclische cyclohexan-derivate
ATE447939T1 (de) Dosierungsformen enthaltend thyroidhormone und deren herstellungsverfahren
TW200509863A (en) Irradiation device for medical use
RU2007122391A (ru) S-миртазапин для лечения приливов
AR059945A1 (es) Metodos para tratar afecciones malignas de celulas b que utilizan una molecula de fusion taci-ig
ATE526963T1 (de) Pharmazeutische zusammensetzung mit olmesartan- medoxomil
ATE527997T1 (de) Verwendung von aminapthon zur herstellung eines medikaments zur behandlung von arteriopathien
AR048672A1 (es) Tabletas de desintegracion que comprenden licarbazepina
CY1111361T1 (el) Νεα προσδεματα συναγωνιστες των υποδοχεων rar, χρηση στην ανθρωπινη ιατρικη καθως και στην κοσμετολογια
ATE530172T1 (de) Pharmazeutische formulierungen mit clopidogrel
DE60312642D1 (de) Pharmazeutische zusammensetzung mit modifizierter freisetzung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties